Prospect Capital Corp loans Matrixx Initiatives USD 80 million for recapitalization

August 12
10:22 AM 2013

Prospect Capital Corp said it provided an USD 80 million loan to Matrixx Initiatives Inc. The floating-rate first-lien senior-secured loan would be used for the recapitalization of Matrixx, a consumer healthcare company. Prospect Capital also provided a senior-secured revolving credit facility to the healthcare firm. Matrixx is best known for its over-the-counter cold medications that carry the Zicam brand. Zicam is a preferred OTC medication for cold prevention and recovery and is considered as one of the top twelve brands in the market. Private equity company H.I.G Capital Llc holds a controlling share in Matrixx.

Prospect Capital Management Managing Director Jason Wilson said "Zicam's leading market position, nationwide distribution, and product innovation demonstrate the strength, diversity, and growth potential of the brand. With this investment, Prospect so far in 2013 has closed one or more transactions with H.I.G.'s offices in Miami, San Francisco, Boston, and New York." In 2013, Prospect was able to close more than USD 1.8 billion originations.

© 2022 VCPOST, All rights reserved. Do not reproduce without permission.


Join the Conversation

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics